Hartong R, Wiersinga W M, Lamers W H, Plomp T A, Broenink M, van Beeren M H
Department of Endocrinology, University of Amsterdam, The Netherlands.
Horm Metab Res Suppl. 1987;17:34-43.
The hypothesis that amiodarone (AM) acts by inducing a local 'hypothyroid-like' state in thyroid hormone-responsive tissues was investigated in rat liver. Hypothyroid rats, pretreated orally for 8 consecutive days with AM (200 mg/kg) or water, were given a single i.p. injection of equimolar doses of T4, T3 or rT3 (1.00 to 1.20 mg/kg). Six hours later, the rats were killed and liver nuclear T3 receptor occupancy was determined. Simultaneously, the activity of two thyroid hormone-responsive enzymes was measured, together with the levels of their respective mRNAs by hybridization to specific cDNAs. The enzymes were phosphoenolpyruvate carboxykinase and glutamine synthetase. AM showed no effect on nuclear T3 receptor occupancy in rats injected with either vehicle, rT3, or T3, but it completely blocked the increase in receptor occupancy in rats injected with T4. With regard to postreceptor effects, T4 and T3 elicited an approximately two-fold increase in the levels of the mRNAs coding for the two enzymes, whereas rT3 had no effect. The increase of the two mRNAs was potentiated by AM, but this is probably secondary to an AM-induced state of anorexia. Remarkably, this potentiating effect of AM was not observed at the protein-level: enzyme activities were lower in rats pretreated with AM. AM-pretreatment thus results in lower enzyme activity to mRNA ratios for both enzymes, irrespective of hormonal treatment. Therefore, although no conclusions can be drawn about possible effects of AM at the transcriptional level, it is concluded that AM interferes with thyroid hormone responsive gene expression in rat liver at a post-transcriptional level. As a consequence, in the present experimental design the livers of AM-treated rats resemble the liver of hypothyroid rats with regard to specific enzyme activities, but not with regard to either nuclear T3 receptor occupancy or the levels of specific mRNAs.
在大鼠肝脏中研究了胺碘酮(AM)通过在甲状腺激素反应性组织中诱导局部“甲状腺功能减退样”状态发挥作用的假说。对甲状腺功能减退的大鼠连续8天口服给予AM(200 mg/kg)或水进行预处理,然后腹腔注射等摩尔剂量的T4、T3或反T3(rT3)(1.00至1.20 mg/kg)。6小时后,处死大鼠并测定肝细胞核T3受体占有率。同时,测量两种甲状腺激素反应性酶的活性,并通过与特异性cDNA杂交测定其各自mRNA的水平。这两种酶是磷酸烯醇式丙酮酸羧激酶和谷氨酰胺合成酶。AM对注射溶剂、rT3或T3的大鼠的核T3受体占有率没有影响,但它完全阻断了注射T4的大鼠受体占有率的增加。关于受体后效应,T4和T3使编码这两种酶的mRNA水平增加约两倍,而rT3没有影响。AM增强了这两种mRNA的增加,但这可能继发于AM诱导的厌食状态。值得注意的是,在蛋白质水平未观察到AM的这种增强作用:用AM预处理的大鼠的酶活性较低。因此,无论激素处理如何,AM预处理都会导致这两种酶的酶活性与mRNA比率降低。因此,尽管无法得出关于AM在转录水平可能作用的结论,但可以得出结论,AM在转录后水平干扰大鼠肝脏中甲状腺激素反应性基因的表达。因此,在本实验设计中,AM处理的大鼠肝脏在特定酶活性方面类似于甲状腺功能减退大鼠的肝脏,但在核T3受体占有率或特定mRNA水平方面则不然。